Trial intelligence / Profile preview

Cooled RFA vs Steroid Injection for Hip Osteoarthritis Pain

NCT03647332Unknown

Sponsor
Rothman Orthopaedics
Start
Jul 2017
Primary completion
Dec 2019
Countries
1
01

Overview

Randomised, single-blind trial in osteoarthritis of the hip, sponsored by Rothman Orthopaedics. Primary endpoint: Pain at 24 weeks. Status: unknown.

02

Conditions

osteoarthritis of the hip

Beyond the preview

Go deeper on NCT03647332.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03647332.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call